Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Novartis says study shows secukinumab works in spinal inflammation condition

  Novartis AG said one-year results of its drug secukinumab show it is effective in treating patients with ankylosing spondylitis (AS), a debilitating joint condition of the spine.   The Basel-based drugmaker said it will present detailed results from the study at a rheumatism conference in Rome this week.       (Reporting by Katharina […]

Read More »

Roche says Actemra drug wins breakthrough therapy nod from FDA

  Roche said it received breakthrough therapy designation from the U.S. health regulator for its Actemra treatment in systemic sclerosis.   The Basel-based drugmaker said it will present new data from two studies on the drug in patients with early rheumatoid arthritis and systemic juvenile idiopathic arthritis at a rheumatism conference in Rome this week. […]

Read More »

Your Birth Month May Predict Your Health, Reveals

Data Scientists Find Connections Between Birth Month And Health Columbia University scientists have developed a computational method to investigate the relationship between birth month and disease risk. The researchers used this algorithm to examine New York City medical databases and found 55 diseases that correlated with the season of birth. Overall, the study indicated people […]

Read More »

Five (Non-Cancer) Areas Bristol-Myers Squibb Is Pursuing Hard

Outside of cancer immunotherapy, Bristol-Myers Squibb is interested in pursuing five areas: Heart failure, virology, rare disease, immunoscience and fibrosis. Donnie McGrath, a vp at Bristol-Myers Squibb and head of search and evaluation, discussed business development strategy in an interview at this week’s Redefining Early Stage Investments (RESI) conference in Houston. Hey, check out all […]

Read More »

Receptos Allegedly Rebuffs AstraZeneca PLC Bid But Rivals Gilead, Teva are Circling

June 10, 2015By Mark Terry, Breaking News Staff It was reported yesterday by Proactive Investors’ Philip Waller that San Diego-based Receptos (RCPT) has rejected takeover bids by U.K.-based AstraZeneca PLC (AZN), Israel-based Teva Pharmaceutical Industries Ltd. (TEVA) and Foster City, Calif.-based Gilead Sciences, Inc. (GILD). Back in April 2015, Receptos announced that it had […]

Read More »

Bayer Dumps Diabetes Care Biz for $1.15 Billion

German pharma giant Bayer AG (BAYZF) will sell its diabetes business to Panasonic’s healthcare unit for around $1.15 billion, as the company begins shedding nonessential assets as part of a mission to refocus on life sciences. The deal will close in the first quarter of 2016, said the companies. The products included in the sale […]

Read More »

FDA Advisors Back Regeneron, Sanofi’s New Heart Drug With Limits

June 10, 2015By Riley McDermid, Breaking News Sr. Editor Tarrytown, N.Y.-based Regeneron Pharmaceuticals, Inc. (REGN) is enjoying a nice boost Wednesday, the day after the U.S. Food and Drug Administration (FDA) recommended approval for the company’s application for cholesterol lowering drug Praluent (alirocumab). The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. […]

Read More »

Roche’s Actemra Wins Breakthrough Nod From FDA

Roche Receives U.S. FDA Breakthrough Therapy Designation For ACTEMRA/Roactemra In Systemic Sclerosis, And Will Present New Study Results At EULAR 2015 ACTEMRA/RoACTEMRA monotherapy and combination treatment regimens almost double sustained remission rates in people with early rheumatoid arthritis1 Five year sustained efficacy of ACTEMRA/RoACTEMRA demonstrated in children with systemic juvenile idiopathic arthritis2 Global Phase 3 […]

Read More »

Woman gives birth after childhood ovarian tissue transplant

A Congolese-Belgian woman has become the first in the world to give birth to a healthy child after doctors restored her fertility by transplanting ovarian tissue that was removed and frozen when she was a child. The woman, who was diagnosed with sickle-cell anemia when she was five and emigrated to Belgium at age 11, […]

Read More »

One dose of cervical cancer vaccine may suffice, scientists say

A single dose of GlaxoSmithKline’s human papillomavirus (HPV) vaccine could prevent the majority of cervical cancers, saving money and improving uptake of a potentially life-saving vaccination, scientists said on Wednesday. GSK’s Cervarix, which targets two strains of HPV that cause about 70 percent of cervical cancers, is currently given in two- or three-dose schedules, but […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom